Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01974752
Title Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT)
Acronym SUMIT
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | GBR | FRA | ESP | DEU | CAN | BEL

Facility Status City State Zip Country Details
Research Site Los Angeles California United States Details
Research Site Aurora Colorado United States Details
Research Site Atlanta Georgia United States Details
Research Site Lutherville Maryland United States Details
Research Site St. Louis Missouri United States Details
Research Site New York New York United States Details
Research Site Philadelphia Pennsylvania United States Details
Research Site Edegem Belgium Details
Research Site Gent Belgium Details
Research Site Kortrijk Belgium Details
Research Site Leuven Belgium Details
Research Site Toronto Ontario Canada Details
Research Site Montreal Quebec Canada Details
Research Site Olomouc Czech Republic Details
Research Site Praha Czech Republic Details
Research Site Hus Finland Details
Research Site Nice Cedex 2 France Details
Research Site Paris Cedex 5 France Details
Research Site Heidelberg Germany Details
Research Site München Germany Details
Research Site Jerusalem Israel Details
Research Site Ramat Gan Israel Details
Research Site Leiden Netherlands Details
Research Site Barcelona Spain Details
Research Site L'Hospitalet de Llobregat Spain Details
Research Site Sevilla Spain Details
Research Site Valencia Spain Details
Research Site Glasgow United Kingdom Details
Research Site Northwood United Kingdom Details
Research Site Nottingham United Kingdom Details
Research Site Swansea United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field